Gastric banding cuts type 2 in overweight people

While the benefits of gastric banding for obese people with type 2 diabetes has been well documented, this study from the Centre for Obesity Research and Education at Monash University is the first randomly controlled trial to show the same benefit for type 2 diabetes patients with a BMI between 25 and 30.

Researchers randomly allocated 51 overweight patients who had been diagnosed with diabetes in the past five years to multidisciplinary diabetes care plus laparoscopic adjustable gastric band surgery or multidisciplinary care alone.

Multidisciplinary care involved consultations with a doctor every 3–6 months and sessions with a dietitian. All participants were advised to do 150 minutes of moderate exercise each week.

After two years, 12 (52%) of the patients in the surgery group had achieved diabetes remission, 11 of whom lost at least 10% of their bodyweight.

This was compared to two patients (8%) in the multidisciplinary care